---
schema_version: "secwatch.filing_event.v1"
accession: "0001872789-24-000031"
form_type: "8-K"
ticker: "EMBC"
cik: "0001872789"
company_name: "Embecta Corp."
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T18:09:47.920239+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Embecta Q4 beats; discontinues patch pump; restructuring saves $60-65M annually; FY2025 EPS guidance $2.70-2.90

## Summary
- Q4 reported rev $286.1M (+1.5%), GAAP EPS $0.25, adjusted EPS $0.45.
- FY2024 rev $1,123.1M (+0.2%), adjusted EPS $2.45, GAAP EPS $1.34.
- Discontinues insulin patch pump; expects $35-45M pre-tax charges in FY2025; annualized savings $60-65M.
- FY2025 guidance: rev $1,093-1,110M, adjusted EPS $2.70-2.90, adj. EBITDA margin 35.5-36.5%.
- Board declares $0.15/share dividend payable Dec 18, 2024 to holders of record Dec 6, 2024.

## SEC filing metadata
- accession: 0001872789-24-000031
- form_type: 8-K
- ticker: EMBC
- cik: 0001872789
- company_name: Embecta Corp.
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 2.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1872789/000187278924000031/0001872789-24-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1872789/000187278924000031/embc-20241126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001872789-24-000031
- JSON: https://secwatch.observer/filing/0001872789-24-000031.json
- Plain text: https://secwatch.observer/filing/0001872789-24-000031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.